TYROBP is a potential prognostic biomarker of clear cell renal cell carcinoma

Clear cell renal cell carcinoma (ccRCC) exhibits high recurrence and metastasis rates. Although target therapy has significantly improved the prognosis of some patients with ccRCC, the median survival rate remains poor. Thus, there remains a need for the identification of novel potential targets for...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Ping, Xiang, Tingting, Wang, Jing, Lv, Run, Wu, Guangzhen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7714062/
https://www.ncbi.nlm.nih.gov/pubmed/33015999
http://dx.doi.org/10.1002/2211-5463.12993

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7714062/
https://www.ncbi.nlm.nih.gov/pubmed/33015999
http://dx.doi.org/10.1002/2211-5463.12993

Ejemplares similares